A Win For Akouos Inc.
Tue, Sep 13, 2022 at 07:19 PM
Akouos Inc. (AKUS:NASDAQ) soared at $4.48, a gain of 28%. On Tue, Sep 13, 2022, AKUS:NASDAQ hit a New 2-Week High of $4.48. The stock appeared on our News Catalysts scanner on Tue, Sep 13, 2022 at 01:04 PM in the 'BIOTECH' category. From Tue, Aug 30, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Wed, Jun 29, 2022 at $7.15 with a volume of 11M+.
About Akouos Inc. (AKUS:NASDAQ)
Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing.
Top 10 Gainers:
- Akero Therapeutics, Inc. (AKRO:NASDAQ), 136.76%
- Aditxt Inc. (ADTX:NASDAQ), 113.75%
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 101.04%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 79.32%
- 89bio, Inc. (ETNB:NASDAQ), 40%
- Motorsport Games Inc. (MSGM:NASDAQ), 28.14%
- Akouos Inc. (AKUS:NASDAQ), 28%
- Infobird Co. Ltd (IFBD:NASDAQ), 27.98%
- Golden Path Acquisition Corporation (GPCO:NASDAQ), 22.39%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 22.26%